Cargando…
Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?
BACKGROUND: Alzheimer's Disease (AD), the most common type of dementia, is a chronic, progressive, and neurodegenerative brain discomfort that causes the be damage to brain cells. Although there is no definitive treatment for AD, various drug treatments are used to reduce and control the sympto...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410945/ https://www.ncbi.nlm.nih.gov/pubmed/37559042 http://dx.doi.org/10.1186/s12962-023-00463-7 |